Ho Yeong Lim

9PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsTissue engineeringGene and molecular therapyDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 07, 2026
Second-Line and Subsequent Therapies after Atezolizumab Plus Bevacizumab Treatment in Hepatocellular Carcinoma: A Multicenter Prospective Cohort Study.

Yuri Cho, Jeong-Hoon Lee, Baek-Yeol Ryoo

|Jan 23, 2026
Threshold Dose-Response Association Between Alcohol Consumption and Risk of Young-Onset Pancreatic Cancer: A Nationwide Korean Cohort Study of Young Adults Age 20-39 Years.

Joo-Hyun Park, Jung Yong Hong, Kyungdo Han

|Aug 14, 2024
Efficacy and safety of bintrafusp alfa in 2 phase I expansion cohorts with advanced HCC.

Ho Yeong Lim, Jeong Heo, Julio A Peguero

|Feb 14, 2024
Activity of Tepotinib in Hepatocellular Carcinoma With High-Level MET Amplification: Preclinical and Clinical Evidence.

Shukui Qin, Hongming Pan, Jean Frédéric Blanc

|Jun 19, 2023
Sorafenib for 9,923 Patients with Hepatocellular Carcinoma: An Analysis from National Health Insurance Claim Data in South Korea.

Sojung Han, Do Young Kim, Ho Yeong Lim

|Apr 19, 2023
Increased Risk of Young-Onset Digestive Tract Cancers Among Young Adults Age 20-39 Years With Nonalcoholic Fatty Liver Disease: A Nationwide Cohort Study.

Joo-Hyun Park, Jung Yong Hong, Jay J Shen

Pageof 2

Frequent Collaborators

2 joint publications

Kyungdo Han

2 joint publications

Baek-Yeol Ryoo

2 joint publications

Joon Oh Park

2 joint publications

Jay J Shen